Molnupiravir, an antiviral drug used to treat patients with COVID-19, appears to be driving SARS-CoV-2 to mutate and evolve, with some of these new viruses being transmitted onwards, a new study has shown.
Antiviral drug molnupiravir linked to new mutations in SARS-CoV-2
- Post author:
- Post published:September 26, 2024
- Post category:uncategorized